X

pharmaceuticals

Vertex Pharmaceuticals reports 14% growth in Q1 revenue: Infographic

Vertex Pharmaceuticals (NASDAQ: VRTX) reported first-quarter 2021 financial results after the regular market hours on Thursday. The pharmaceutical firm reported…

Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results

Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9%…

Johnson & Johnson (JNJ) reports Q1 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Two areas that provide Pfizer (PFE) with ample opportunity for future growth

Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront…

It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why

After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical…

Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues?

The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy…

Walgreens Boots Alliance Inc. (WBA) Q2 2021 Earnings Call

Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of…

Here’s what you need to know before investing in Amgen (AMGN)

The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely…

Walgreens Boots Alliance, Inc. (WBA) Q2 2021 Earnings Call Transcript

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President…

Walgreens Boots Alliance (WBA) Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second-quarter 2021 earnings results today. Sales increased 4.6% to $32.8 billion. It is…

What’s happening on the COVID-19 front? Here are a few updates.

Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went…

These two factors will play out in favor of Pfizer (PFE) going forward

Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past 12 months. The company had a huge…

Abbott’s (ABT) stock can give high returns, thanks to COVID-related tailwinds

The financial performance of Abbott Laboratories (NYSE: ABT) has been positively impacted by the high demand for COVID-related diagnostic services.…

Medtronic (MDT) goes the extra mile to emerge stronger from virus crisis

The pandemic has influenced the healthcare industry significantly, but not all the segments are impacted in the same way. While…

Solid pipeline makes ImmunoGen (IMGN) a good long-term investment

ImmunoGen Inc. (NASDAQ: IMGN) last week reported a profit after incurring losses in the first three quarters of last year.…

CVS Health Corp. (CVS) Earnings: 4Q20 Key Numbers

CVS Health Corporation (NYSE: CVS) reported fourth quarter 2020 earnings results today. Total revenues increased 4% to $69.5 billion compared…

Infographic: Highlights of Aurora Cannabis (ACB) Q2 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend.…

Eylea recovery, COVID antibody cocktail make Regeneron an attractive bet

After last year's mixed performance, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) looks to take advantage of the robust pipeline and the…

Strong pipeline, M&A synergies to keep Bristol Myers on growth path

Bristol Myers Squibb Company (NYSE: BMY) is thriving on its multi-pronged growth plan, based on strategic acquisitions and the promising…

Bristol Myers (BMY) stock gains after Q4 results beat Street view

Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company's stock gained in the pre-market session soon after…

Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged…